A very interesting study conducted by Liang et al. [156] not only identified ARID1A as a potential driver gene in endometrial cancer, but also demonstrated that ARID1A mutations frequently co-occur with mutations, leading to activation in the PI3K/AKT pathway. Here, PIK3CA is linked to endometrial cancer.